๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

A randomized, phase II, three-arm study of two schedules of ixabepilone or paclitaxel plus bevacizumab as first-line therapy for metastatic breast cancer

โœ Scribed by Rugo, Hope S.; Campone, Mario; Amadori, Dino; Aldrighetti, Daniela; Conte, PierFranco; Wardley, Andrew; Villanueva, Cristian; Melisko, Michelle; McHenry, M. Brent; Liu, David; Lee, Francis; Pivot, Xavier


Book ID
121634081
Publisher
Springer US
Year
2013
Tongue
English
Weight
333 KB
Volume
139
Category
Article
ISSN
0167-6806

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


A phase II study of paclitaxel plus carb
โœ Edith A. Perez; David W. Hillman; Philip J. Stella; James E. Krook; Lynn C. Hart ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 96 KB ๐Ÿ‘ 3 views

## BACKGROUND. This Phase II multicenter study evaluated the efficacy and toxicity of paclitaxel (200 mg/m 2 by 3-hour infusion) with carboplatin (area under the curve 6 mg/mL per minute) administered every 3 weeks as first-line therapy for women with metastatic breast carcinoma. ## METHODS. Eligi